Number of mutations per patient by treatment arm
| No. of mutations per patient . | n (%) . | ||
|---|---|---|---|
| Arm A: decitabine (n = 56) . | Arm B: decitabine + bortezomib (n = 62) . | All patients (N = 118) . | |
| 0 | 2 (3.6) | 4 (6.5) | 6 (5.1) |
| 1 | 15 (26.8) | 12 (19.4) | 27 (22.9) |
| 2 | 13 (23.2) | 19 (30.6) | 32 (27.1) |
| 3 | 16 (28.6) | 8 (12.9) | 24 (20.3) |
| 4 | 7 (12.5) | 12 (19.4) | 19 (16.1) |
| 5 | 2 (3.6) | 4 (6.5) | 6 (5.1) |
| 6 | 1 (1.8) | 2 (3.2) | 3 (2.5) |
| 7 | 0 (0.0) | 1 (1.6) | 1 (0.8) |
| Median (range) | 2 (0-6) | 2 (0-7) | 2 (0-7) |
| No. of mutations per patient . | n (%) . | ||
|---|---|---|---|
| Arm A: decitabine (n = 56) . | Arm B: decitabine + bortezomib (n = 62) . | All patients (N = 118) . | |
| 0 | 2 (3.6) | 4 (6.5) | 6 (5.1) |
| 1 | 15 (26.8) | 12 (19.4) | 27 (22.9) |
| 2 | 13 (23.2) | 19 (30.6) | 32 (27.1) |
| 3 | 16 (28.6) | 8 (12.9) | 24 (20.3) |
| 4 | 7 (12.5) | 12 (19.4) | 19 (16.1) |
| 5 | 2 (3.6) | 4 (6.5) | 6 (5.1) |
| 6 | 1 (1.8) | 2 (3.2) | 3 (2.5) |
| 7 | 0 (0.0) | 1 (1.6) | 1 (0.8) |
| Median (range) | 2 (0-6) | 2 (0-7) | 2 (0-7) |